Patents by Inventor Joanna M. Koziara

Joanna M. Koziara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic compositions for treatment of human immunodeficiency virus
    Patent number: 11744802
    Abstract: A solid oral dosage form is provided, comprising a compound of Formula I or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtricitabine or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 6, 2022
    Date of Patent: September 5, 2023
    Assignee: Gilead Sciences, Inc.
    Inventors: Benjamin Micah Collman, Lei Hong, Joanna M. Koziara
  • THERAPEUTIC COMPOSITIONS FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS
    Publication number: 20220378798
    Abstract: A solid oral dosage form is provided, comprising a compound of Formula I or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtricitabine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 6, 2022
    Publication date: December 1, 2022
    Inventors: Benjamin Micah Collman, Lei Hong, Joanna M. Koziara
  • THERAPEUTIC COMPOSITIONS FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS
    Publication number: 20210052502
    Abstract: A solid oral dosage form is provided, comprising a compound of Formula I or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtricitabine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 6, 2020
    Publication date: February 25, 2021
    Inventors: Benjamin Micah Collman, Lei Hong, Joanna M. Koziara
  • Therapeutic compositions for treatment of human immunodeficiency virus
    Patent number: 10548846
    Abstract: A solid oral dosage form is provided, comprising a compound of Formula I or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtricitabine or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: February 4, 2020
    Assignee: Gilead Sciences, Inc.
    Inventors: Benjamin Micah Collman, Lei Hong, Joanna M. Koziara
  • Use of solid carrier particles to improve the processability of a pharmaceutical agent
    Patent number: 10039718
    Abstract: The invention provides a composition comprising, a compound of formula (I): or a pharmaceutically acceptable salt thereof and a plurality of solid carrier particles, as well as methods for using the composition to inhibit the activity of cytochrome P-450.
    Type: Grant
    Filed: May 1, 2009
    Date of Patent: August 7, 2018
    Assignee: Gilead Sciences, Inc.
    Inventors: Joanna M. Koziara, Mark M. Menning, Robert G. Strickley, Richard Yu, Brian P. Kearney, Anita A. Mathias
  • PHARMACEUTICAL FORMULATIONS COMPRISING TENOFOVIR AND EMTRICITABINE
    Publication number: 20180177734
    Abstract: The invention provides a solid oral dosage form comprising tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtricitabine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 29, 2016
    Publication date: June 28, 2018
    Inventors: Joanna M. Koziara, Scott McCallister
  • Therapeutic Compositions for Treatment of Human Immunodeficiency Virus
    Publication number: 20170189337
    Abstract: A solid oral dosage form is provided, comprising a compound of Formula I or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtricitabine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 8, 2016
    Publication date: July 6, 2017
    Inventors: Benjamin Micah Collman, Lei Hong, Joanna M. Koziara
  • PHARMACEUTICAL FORMULATIONS
    Publication number: 20170000807
    Abstract: The invention provides a solid oral dosage form comprising tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtricitabine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 29, 2016
    Publication date: January 5, 2017
    Inventors: Joanna M. Koziara, Scott McCallister
  • PHARMACEUTICAL COMPOSITIONS OF RANOLAZINE AND DRONEDARONE
    Publication number: 20160213569
    Abstract: The present disclosure relates to a solid composition comprising ranolazine and a spray-dried phosphoric acid salt of dronedarone in a bilayer tablet.
    Type: Application
    Filed: April 6, 2016
    Publication date: July 28, 2016
    Inventors: Michael Gerber, Neal Huang, Joanna M. Koziara, Feng Zhang
  • TABLETS FOR COMBINATION THERAPY
    Publication number: 20150150810
    Abstract: The invention provides solid dose forms (e.g. tablets) comprising a compound of Formula I, a compound of Formula II, a compound of Formula III and a salt of Formula IV.
    Type: Application
    Filed: February 6, 2015
    Publication date: June 4, 2015
    Applicant: GILEAD SCIENCES, INC.
    Inventors: Reza OLIYAI, Mark M. MENNING, Joanna M. KOZIARA
  • SPRAY DRIED FORMULATIONS
    Publication number: 20150045366
    Abstract: The invention provides a spray dried formulation of Compound I: or a salt thereof as well as compositions comprising the spray dried formulations, and methods for making and using the spray dried formulations.
    Type: Application
    Filed: February 28, 2013
    Publication date: February 12, 2015
    Applicant: Gilead Sciences, Inc.
    Inventor: Joanna M. Koziara
  • PHARMACEUTICAL COMPOSITIONS OF RANOLAZINE AND DRONEDARONE
    Publication number: 20150037410
    Abstract: The present disclosure relates to a solid composition comprising ranolazine and a spray-dried phosphoric acid salt of dronedarone in a bilayer tablet.
    Type: Application
    Filed: July 29, 2014
    Publication date: February 5, 2015
    Applicant: Gilead Sciences, Inc.
    Inventors: Michael Gerber, Neal Huang, Joanna M. Koziara, Feng Zhang
  • AMORPHOUS SOLID SALTS
    Publication number: 20140187771
    Abstract: The invention provides an amorphous solid of a compound of formula (I) or of a salt thereof as well as compositions comprising the amorphous solids, and methods for making and using the amorphous solids.
    Type: Application
    Filed: April 30, 2012
    Publication date: July 3, 2014
    Applicant: Gilead Sciences, Inc.
    Inventors: Joanna M. Koziara, Anne Luong, Keiko Sujino, Richard Yu
  • TABLETS FOR COMBINATION THERAPY
    Publication number: 20100285122
    Abstract: The invention provides solid dose forms (e.g. tablets) comprising a compound of Formula I, a compound of Formula II, a compound of Formula III and a salt of Formula IV.
    Type: Application
    Filed: February 4, 2010
    Publication date: November 11, 2010
    Applicant: Gilead Sciences, Inc.
    Inventors: Reza Oliyai, Mark M. Menning, Joanna M. Koziara
  • USE OF SOLID CARRIER PARTICLES TO IMPROVE THE PROCESSABILITY OF A PHARMACEUTICAL AGENT
    Publication number: 20090324729
    Abstract: The invention provides a composition comprising, a compound of formula (I): or a pharmaceutically acceptable salt thereof and a plurality of solid carrier particles, as well as methods for using the composition to inhibit the activity of cytochrome P-450.
    Type: Application
    Filed: May 1, 2009
    Publication date: December 31, 2009
    Applicant: GILEAD SCIENCES, INC.
    Inventors: Joanna M. Koziara, Mark M. Menning, Reza Oliyai, Robert G. Strickley, Richard Yu, Brian P. Kearney, Anita A. Mathias